Frontiers | Extracellular traps and the role in thrombosis
Thrombotic Microangiopathy can result from different molecular... | Download Scientific Diagram
Full article: The utility of platelet activation biomarkers in thrombotic microangiopathies
Evidence for secondary thrombotic microangiopathy in COVID-19 | medRxiv
Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients | Scientific Reports
Renal Thrombotic Microangiopathy: A Review - American Journal of Kidney Diseases
Cell-Free DNA: An Upcoming Biomarker in Transplantation - American Journal of Transplantation
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation ...
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura - Kidney International
Diagnosis and treatment of thrombotic microangiopathy - Thompson - 2022 - International Journal of Laboratory Hematology - Wiley Online Library
JCM | Free Full-Text | Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
JCM | Free Full-Text | Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise
Clinical Evaluation and Management of Thrombotic Microangiopathy - Leisring - Arthritis & Rheumatology - Wiley Online Library
Thrombotic Microangiopathy Syndromes—Common Ground and Distinct Frontiers - Advances in Chronic Kidney Disease
Circulating markers of neutrophil extracellular trap formation are... | Download Scientific Diagram
Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy - ScienceDirect
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics | Nature Reviews Nephrology
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation ...
JPM | Free Full-Text | Kidney Allograft Monitoring by Combining Donor-Derived Cell-Free DNA and Molecular Gene Expression: A Clinical Management Perspective
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium | Nature Reviews Cardiology
Cureus | Pregnancy-Induced Thrombotic Microangiopathy in Systematic Lupus Erythematosus: A Case Report | Article
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation ...
Frontiers | Extracellular DNA—A Danger Signal Triggering Immunothrombosis
Eculizumab in Transplant-Associated Thrombotic Microangiopathy - Prajwal Dhakal, Smith Giri, Ranjan Pathak, Vijaya Raj Bhatt, 2017
Frontiers | Pathophysiological mechanisms of thrombosis in acute and long COVID-19
Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury | Nature Reviews Nephrology
VEGF Inhibition and Renal Thrombotic Microangiopathy | NEJM
Serum Neutrophil Extracellular Trap Levels Predict Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
How I treat thrombotic microangiopathy in the era of rapid genomics - ScienceDirect
